BioTelemetry, Inc.
BEAT
BEAT was delisted on the 8th of February, 2021.
238 hedge funds and large institutions have $2.3B invested in BioTelemetry, Inc. in 2020 Q4 according to their latest regulatory filings, with 66 funds opening new positions, 57 increasing their positions, 88 reducing their positions, and 36 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 2 → 6 (+4)
83% more first-time investments, than exits
New positions opened: 66 | Existing positions closed: 36
58% more capital invested
Capital invested by funds: $1.45B → $2.3B (+$850M)
14% more funds holding
Funds holding: 209 → 238 (+29)
1% more call options, than puts
Call options by funds: $27.4M | Put options by funds: $27.2M
35% less repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 88
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
+$64.8M |
| 2 |
GL
Governors Lane
New York
|
+$34.2M |
| 3 |
SGCM
Sand Grove Capital Management
London,
United Kingdom
|
+$29.3M |
| 4 |
GCL
Glazer Capital LLC
New York
|
+$16.2M |
| 5 |
SCC
Spring Creek Capital
Wichita,
Kansas
|
+$14M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$50.6M |
| 2 |
Millennium Management
New York
|
-$38.6M |
| 3 |
SIMG
Stephens Investment Management Group
Houston,
Texas
|
-$35.8M |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$28M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$22.1M |
BEAT Hedge Fund Activity: Q4 2020 in Review
238 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in BioTelemetry, Inc. (BEAT) for Q4 2020, worth a combined $2.3B — up 58% from $1.45B a quarter earlier.
Buyers outnumbered sellers: 66 funds opened new BEAT positions and 36 closed out — a net gain of 30 holders — while 57 added to existing stakes and 88 trimmed.
The largest buyer was Alpine Associates Management, opening a new position worth an estimated $64.8M. The largest seller was Credit Suisse, cutting an estimated $50.6M.
- 238 institutional investors held BioTelemetry, Inc. (BEAT) as of Q4 2020, up from 209 in Q3 2020.
- Funds reported $2.3B of BioTelemetry, Inc. stock for Q4 2020, up 58% quarter-over-quarter.
- 66 funds opened new BioTelemetry, Inc. positions in Q4 2020 and 36 closed out, a net change of +30 holders.
- The largest BioTelemetry, Inc. buyer in Q4 2020 was Alpine Associates Management, an estimated $64.8M added.
- The largest BioTelemetry, Inc. seller in Q4 2020 was Credit Suisse, an estimated $50.6M sold.
Based on aggregated 13F filings for Q4 2020.